Estrogen

Protective estrogen (2-hydroxyestrone) lowers cancer risk. Menopausal hormone therapy is identified as the most effective evidence-based treatment for vasomotor symptoms. The Menopause Society states that women over 65 may safely continue hormone therapy. The article presents estrogen as supporting women's happiness, bonding, receptivity, and sexual openness. Systemic menopausal hormone therapy may benefit hot flashes and longer-term concerns involving cardiovascular disease, dementia, osteoporosis, muscle health, and metabolic health. Continuing estrogen monotherapy after age 65 significantly reduces all-cause mortality compared to never-users. Estriol, dominant during pregnancy, has anti-inflammatory and anti-cancer protective properties. The article frames pathological testosterone-to-estrogen conversion as something that can be stopped by restoring insulin health and increasing growth hormone. Menopausal symptoms can resolve rapidly once the adrenal glands receive adequate cholesterol substrate. Iodine supplementation is highly effective at addressing fibrocystic breast disease by correcting the root cause — the estrogen-iodine imbalance. Lowering estrogen through cruciferous…